Here we share important milestones, updates from our research and fundraising activities, and the progress of the Cancer Immunotherapy Endowment Fund. Even small steps bring us closer to our goal – bringing MBTA immunotherapy to patients.
Launch of the Fund
The Cancer Immunotherapy Endowment Fund has officially launched. Our mission is clear: to support the transition of MBTA immunotherapy from research to clinical practice and to make this innovative treatment available for patients worldwide.
First Successful Donations
The first donations have been received through our secure Stripe and PayPal gateways. We are grateful to our early supporters for their trust. Your contributions show that people believe in our mission.
Research Update
Our scientific partner, Dr. Jan Ženka, continues to evaluate MBTA therapy and prepare results for publication. We will share more as the research progresses.
What’s Next
In the coming months, we will strengthen public and donor communication, publish more details on research milestones, and prepare for broader international outreach.